|Bid||137.60 x 900|
|Ask||137.82 x 900|
|Day's Range||134.81 - 139.77|
|52 Week Range||56.16 - 146.00|
|Beta (5Y Monthly)||1.03|
|PE Ratio (TTM)||186.12|
|Earnings Date||Apr 29, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||140.13|
Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Putting progress ahead of politics is just one lesson Omnicell CEO Lipps picked up while building the leader in a key corner of the health care business.
Investors are optimistic about Omnicell (OMCL) owing to its progress with its three-legged strategic, which is driving growth and an impressive 2025 roadmap.